BIO GREEN MED SOLUTION, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $43.0K | $420.0K | $0 | $0 | $0 | $150.0K | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $848.0K | $6.7M | $19.2M | $20.3M | $14.9M | $4.8M | $4.3M | $4.2M |
| SG&A Expense | $7.7M | $5.4M | $6.7M | $7.4M | $7.5M | $5.9M | $5.4M | $5.3M |
| Operating Income | $-8.4M | $-12.0M | $-25.5M | $-27.7M | $-22.4M | $-10.6M | $-9.5M | $-9.5M |
| Operating Margin | — | -27,916.3% | -6,060.2% | — | — | — | -6,365.3% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-3.0M | $-12.0M | $-25.6M | $-25.9M | $-22.2M | $-9.7M | $-8.6M | $-8.5M |
| Income Tax Expense | $7.0K | $-782.0K | $-3.0M | $-4.7M | $-3.7M | $-1.2M | $-1.3M | $-993.0K |
| Net Income | $-3.0M | $-11.2M | $-22.6M | $-21.2M | $-18.5M | $-8.4M | $-7.3M | $-7.5M |
| Net Margin | — | -26,074.4% | -5,370.2% | — | — | — | -4,858.7% | — |
| EPS (Basic) | $-6.45 | $-502.46 | $-1,069.86 | $-0.32 | $-0.35 | $-0.29 | $-0.05 | $-0.16 |
| EPS (Diluted) | $-6.45 | $-502.46 | $-1,069.86 | $-4.54 | $-0.35 | $-0.29 | $-0.05 | $-0.16 |
| Shares Outstanding (Basic) | 2.2M | 22.3M | 21.3M | 67.5M | 53.6M | 43.6M | 150.0M | 144.0M |
| Shares Outstanding (Diluted) | 2.2M | 22.3M | 21.3M | 67.5M | 53.6M | 43.6M | 150.0M | 144.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |